LIVE EVENT
GCN Investor Conference in Newport Beach, CA
OCT 15 · NEWPORT BEACH, CA
LIVE EVENT
A graduate-only research institute focused on fundamental science, with a highly effective licensing arm.
The Weizmann Institute admits only graduate students and concentrates entirely on fundamental research in the natural and exact sciences.
Its technology transfer company, Yeda, is among the most commercially successful in the world, with a licensing record built largely on drug discovery and immunology research.
The institute sits within Israel's science corridor south of Tel Aviv, close to the country's biotechnology and agricultural research base.
Israel's wider ecosystem provides the capital, and the institute provides science that is unusually fundamental for a country better known for applied technology.
Licensing has produced therapeutics used at very large scale, particularly in immunology and neurology.
Company formation tends toward therapeutics, scientific instrumentation, and computational biology rather than software.
Israeli life science venture funds and international pharmaceutical partners are the primary capital sources.
The institute's licensing income also funds continued research, reducing dependence on outside capital for early work.
GCN’s global network includes millions of startups and founders and a broad community of investors, creating opportunities to discover potential connections across university communities.
.webp){kind=logo}
.png)
.png)